Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression

NCT02358343 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT02358343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02358343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ASCEND: A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression
Lead sponsor
University of Washington
Phase
Phase 3
Overall status
Completed
Start date
March 23, 2015
Completion date
December 15, 2017
Enrollment
184 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

depression, end stage renal disease